drugset / Trial / NCT01977300

Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode

NCT01977300

RandomizedParallel-groupDouble-blindTreatment

Summary

Hypothesis: Continuation of an atypical antipsychotic medication in combination with a Mood Stabilizer, following remission from an acute manic episode, lowers the rates of relapse and recurrence of mood episodes compared to discontinuing the antipsychotics within days of resolution of manic symptoms.

Timeline

Start
2003-01
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule 5 mg
Subject Olanzapine Small molecule 25 mg
Subject Risperidone Other / unclassified 1 mg
Subject Risperidone Other / unclassified 6 mg
Background Lithium Unknown
Background Valproate Small molecule

Indications